1. Clinical validation of a radionuclide detector to measure ejection fraction in critically ill patients
- Author
-
Charles J. Hinds, A.W. Nathan, A.C. TlMMINS, and M. Giles
- Subjects
Adult ,Male ,Inotrope ,medicine.medical_specialty ,Resuscitation ,Cardiotonic Agents ,Critical Illness ,medicine.medical_treatment ,Statistics as Topic ,Water-Electrolyte Imbalance ,chemistry.chemical_element ,Technetium ,Sensitivity and Specificity ,Internal medicine ,medicine ,Humans ,Radionuclide Ventriculography ,Stroke ,Aged ,Aged, 80 and over ,Mechanical ventilation ,Radionuclide ,Perchlorates ,Ejection fraction ,business.industry ,Reproducibility of Results ,Stroke Volume ,Middle Aged ,medicine.disease ,Sodium Compounds ,Confidence interval ,Anesthesiology and Pain Medicine ,chemistry ,Echocardiography ,Evaluation Studies as Topic ,Cardiology ,Female ,business - Abstract
The use of a new non-imaging nuclear probe (Cardioscint) capable of continuous online monitoring of left ventricular function is described in critically ill patients undergoing mechanical ventilation. Ejection fraction, measured by the Cardioscint, was compared with that measured by echocardiography. The mean difference was -1.1% (95% confidence interval -2.9 to +0.6%). Mean difference +/- 2 SD was +10.6 to -12.8% (95% confidence intervals +7.5 to 13.6% and -15.8 to -9.0%, respectively). Examples of fluid loading and inotropic support showed comparable changes in stroke counts measured by the Cardioscint and stroke index measured by thermodilution. The Cardioscint is a practical bedside method for continuous or repeated measurement of ejection fraction and for assessing the response to therapeutic interventions in critically ill patients.
- Published
- 1994
- Full Text
- View/download PDF